C0449982||Ligand dependent restoration
C0086418||human
C1336635||TLR3
C1154413||signaling
C0007587||death
C0079419||p53
C0678941||mutant
C0007634||cells
C0079419||p53
C1720950||transcriptional network
C0004793||element sequences
C0079419||p53
C0017262||expression
C0079419||wild type p53
C0079419||wild type p53
C0017263||regulate expression
C0017337||Toll-like-receptor genes
C0017337||Toll-like-receptor genes
C0427861||human cells
C0301872||immune responses
C0027651||tumor-associated
C0079419||p53
C0678941||mutants
C0040624||change-of-spectrum transactivation
C0079419||p53
C0079419||p53
C0678941||mutants
C0017262||activate endogenous expression
C1517488||TLR gene family
C0079419||p53
C0086418||human
C0085983||cancer cell lines
C0314641||transfection
C0079419||p53
C0678941||mutant
C0678941||mutants
C0017262||TLR expression
C1883559||WT levels
C0040624||change-of-spectrum transactivation
C0017337||TLR genes
C1336635||TLR3
C1154413||signaling
C0006826||cancer
C0079419||p53
C0678941||mutants
C0079189||cytokine
C0282554||chemokine
C1817727||apoptotic responses
C1749457||cognate ligand
C0032414||poly(I:C)
C0449982||restoration
C0079419||wild type p53
C0079419||p53
C0678941||mutants
C0079419||p53
C1254351||reactivating drug RITA
C0079419||p53
C0017263||regulation of TLR3 gene expression
C0162638||DNA damage-induced apoptosis
C1336635||TLR3
C1154413||signaling
C0079419||WT
C0678941||mutant
C0079419||p53
C0920425||cancer therapy